Federal award
OSIRIS THERAPEUTICS, INC.
W9113M08C0028
Contract
Obligated and Ceiling
- Obligated (net)
- $5,975,106.01
- Ceiling (potential value, not spending)
- $225,214,552.00
- Current value
- $23,293,237.00
- Gross positive obligations
- $5,996,319.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- OSIRIS THERAPEUTICS, INC. · H4B3L9LH7RV3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- OSIRIS THERAPEUTICS, INC. · H4B3L9LH7RV3
- Awarding agency
- Department of War · sub-agency 2100 · office W911QY
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- W9113M08C0028
- Award type code
- D
- Actions
- 10 · Jan 3, 2008 to Aug 26, 2014
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History10
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Aug 26, 2014 | FY2014 | P00009 | C | −$21,212.99 | — |
| Apr 22, 2010 | FY2010 | P00008 | C | $521,715.00 | — |
| Mar 18, 2010 | FY2010 | P00007 | M | $0.00 | — |
| Aug 10, 2009 | FY2009 | P00006 | C | $21,213.00 | — |
| Aug 6, 2009 | FY2009 | P00005 | B | $0.00 | — |
| Feb 3, 2009 | FY2009 | P00004 | D | $0.00 | — |
| Jan 16, 2009 | FY2009 | P00003 | G | $1,200,000.00 | — |
| Jul 17, 2008 | FY2008 | P00002 | D | $0.00 | — |
| May 6, 2008 | FY2008 | P00001 | M | $0.00 | — |
| Jan 3, 2008 | FY2008 | 0 | — | $4,253,391.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.